
NASDAQConsumer DefensivePackaged Foods
Latest quote
$5.95
−$0.04 · -0.67%
LifeVantage Corporation (LFVN) specializes in the development, manufacture, and distribution of a diverse portfolio of health, wellness, and personal care products. Its offerings encompass nutrigenomic activators (designed to influence genetic expression), a broad array of dietary supplements, cognitive enhancers (nootropics), gut health support (pre- and pro-biotics), weight management solutions, and various personal care items spanning skin care, hair care, bath and body, and targeted relief. The company's product lineup features well-known brands such as Protandim, a series of scientifically validated dietary supplements. Specific examples include LifeVantage Omega+, a blend of DHA/EPA Omega-3s, Omega-7s, and Vitamin D3; LifeVantage ProBio, designed for digestive wellness; the PhysIQ brand for weight management; Petandim, tailored to reduce oxidative stress in dogs; and Axio energy drink mixes. Under the TrueScience brand, LifeVantage also provides anti-aging skincare (e.g., facial cleansers, perfecting lotions, eye serums, creams), hair care solutions (e.g., invigorating shampoos, nourishing conditioners, scalp serums), and an assortment of bath and body products (e.g., body lotion, wash, butter, deodorant) and targeted relief items (e.g., soothing balm, body rub). Distribution occurs through both its proprietary website and an extensive network of independent distributors. LifeVantage maintains a significant international presence, with operations spanning numerous global territories including the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. The corporation's headquarters are situated in Lehi, Utah.
Regular session
$5.95
−$0.04 · -0.67%
Regular session · ET · Market data may be delayed.
LifeVantage Corporation (LFVN) specializes in the development, manufacture, and distribution of a diverse portfolio of health, wellness, and personal care products. Its offerings encompass nutrigenomic activators (designed to influence genetic expression), a broad array of dietary supplements, cognitive enhancers (nootropics), gut health support (pre- and pro-biotics), weight management solutions, and various personal care items spanning skin care, hair care, bath and body, and targeted relief. The company's product lineup features well-known brands such as Protandim, a series of scientifically validated dietary supplements. Specific examples include LifeVantage Omega+, a blend of DHA/EPA Omega-3s, Omega-7s, and Vitamin D3; LifeVantage ProBio, designed for digestive wellness; the PhysIQ brand for weight management; Petandim, tailored to reduce oxidative stress in dogs; and Axio energy drink mixes. Under the TrueScience brand, LifeVantage also provides anti-aging skincare (e.g., facial cleansers, perfecting lotions, eye serums, creams), hair care solutions (e.g., invigorating shampoos, nourishing conditioners, scalp serums), and an assortment of bath and body products (e.g., body lotion, wash, butter, deodorant) and targeted relief items (e.g., soothing balm, body rub). Distribution occurs through both its proprietary website and an extensive network of independent distributors. LifeVantage maintains a significant international presence, with operations spanning numerous global territories including the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. The corporation's headquarters are situated in Lehi, Utah.
Day range
Current $5.95
52-week range
Current $5.95
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
83
Deep Value
Sentiment
60
Mixed
Risk
66
High Risk
Momentum
33
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
LifeVantage Corporation (LFVN) specializes in the development, manufacture, and distribution of a diverse portfolio of health, wellness, and personal care products. Its offerings encompass nutrigenomic activators (designed to influence genetic expression), a broad array of dietary supplements, cognitive enhancers (nootropics), gut health support (pre- and pro-biotics), weight management solutions, and various personal care items spanning skin care, hair care, bath and body, and targeted relief. The company's product lineup features well-known brands such as Protandim, a series of scientifically validated dietary supplements. Specific examples include LifeVantage Omega+, a blend of DHA/EPA Omega-3s, Omega-7s, and Vitamin D3; LifeVantage ProBio, designed for digestive wellness; the PhysIQ brand for weight management; Petandim, tailored to reduce oxidative stress in dogs; and Axio energy drink mixes. Under the TrueScience brand, LifeVantage also provides anti-aging skincare (e.g., facial cleansers, perfecting lotions, eye serums, creams), hair care solutions (e.g., invigorating shampoos, nourishing conditioners, scalp serums), and an assortment of bath and body products (e.g., body lotion, wash, butter, deodorant) and targeted relief items (e.g., soothing balm, body rub). Distribution occurs through both its proprietary website and an extensive network of independent distributors. LifeVantage maintains a significant international presence, with operations spanning numerous global territories including the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. The corporation's headquarters are situated in Lehi, Utah.
Day range
Current $5.95
52-week range
Current $5.95
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 182.59M USD | 228.53M USD | 200.16M USD | 213.4M USD | 206.36M USD |
| Cost of goods sold | 40.97M USD | 44.86M USD | 41.44M USD | 43.39M USD | 38.1M USD |
| Gross profit | 141.61M USD | 183.67M USD | 158.72M USD | 170.01M USD | 168.26M USD |
| Selling, general, and administrative | 135.51M USD | 69.21M USD | 68.47M USD | 71.07M USD | 63.43M USD |
| Operating expenses | 135.51M USD | 171.47M USD | 154.39M USD | 165.75M USD | 160.69M USD |
| Interest income | 164K USD | 431K USD | 430K USD | 198K USD | — |
| Interest expense | — | — | — | — | 10K USD |
| Depreciation and amortization | 2.77M USD | 3.16M USD | 3.58M USD | 3.58M USD | 3.26M USD |
| Operating income | 6.1M USD | 12.2M USD | 4.33M USD | 4.26M USD | 7.58M USD |
| Net income | 5.07M USD | 9.81M USD | 2.94M USD | 2.54M USD | 3.12M USD |
Company facts updated Oct 9, 2026.
Third-party consensus; not a GoAI recommendation.
Limited analyst sample: 3 ratings. Interpret the distribution with caution.
Cash distributions grouped by calendar year; partial years are marked.
$0.175
2025 complete year-67.3% since 2023
2026 partial: $0.145
$0.535
2,023
$0.155
2,024
$0.175
2,025
$0.145
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Sep 1, 2026 | $0.05Quarterly | Sep 1, 2026 | Sep 15, 2026 |
Dividend | Jun 1, 2026 | $0.05Quarterly | Jun 1, 2026 | Jun 15, 2026 |
Dividend | Mar 2, 2026 | $0.045Quarterly | Mar 2, 2026 | Mar 16, 2026 |
Dividend | Dec 1, 2025 | $0.045Quarterly | Dec 1, 2025 | Dec 15, 2025 |
Dividend | Sep 8, 2025 | $0.045Quarterly | Sep 8, 2025 | Sep 16, 2025 |
Dividend | May 30, 2025 | $0.045Quarterly | May 30, 2025 | Jun 13, 2025 |
Ex-dividend Sep 1, 2026
$0.05
Quarterly
Record Sep 1, 2026 · Payment Sep 15, 2026
Ex-dividend Jun 1, 2026
$0.05
Quarterly
Record Jun 1, 2026 · Payment Jun 15, 2026
Ex-dividend Mar 2, 2026
$0.045
Quarterly
Record Mar 2, 2026 · Payment Mar 16, 2026
Ex-dividend Dec 1, 2025
$0.045
Quarterly
Record Dec 1, 2025 · Payment Dec 15, 2025
Ex-dividend Sep 8, 2025
$0.045
Quarterly
Record Sep 8, 2025 · Payment Sep 16, 2025
Ex-dividend May 30, 2025
$0.045
Quarterly
Record May 30, 2025 · Payment Jun 13, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1.95M0.00%2.3T USD0.03%$382.2+0.69%
Avantis U.S. Small Cap Value ETFAVUV1.35M—30.82B USD0.25%$119.81-0.27%
Vanguard Extended Market ETFVXF802.57K0.00%95.4B USD0.05%$235.06+0.83%
Dimensional - US Small Cap ETFDFAS508.76K0.00%33.8B USD0.31%$78.42+0.41%
iShares Micro-Cap ETFIWC208.05K0.02%1.32B USD0.60%$182.81+0.01%
Dimensional - US Core Equity 2 ETFDFAC206.03K0.00%88.2B USD0.21%$45.355+0.54%
U.S. Micro Cap Portfolio ETFDFMC161.07K0.00%7.54B USD0.43%$57.8133+0.20%
EA Bridgeway Omni Small-Cap Value ETFBSVO140K0.01%2.43B USD0.45%$28.41-0.50%
Vanguard Morningstar Total Stock Market ETFVTI
Avantis U.S. Small Cap Value ETFAVUV
Vanguard Extended Market ETFVXF
Dimensional - US Small Cap ETFDFAS
iShares Micro-Cap ETFIWC
Dimensional - US Core Equity 2 ETFDFAC
U.S. Micro Cap Portfolio ETFDFMC
EA Bridgeway Omni Small-Cap Value ETFBSVOAI-generated and delayed market data for informational and educational purposes only. Not investment advice.